Weikang Bio-Technology is launching a new project to research and develop licorice flavonoids for use in therapeutics.

Posted in Corporate Finance News on 10. Jun, 2010

Weikang Bio-Technology Group Co., Inc. (OTC Bulletin Board: WKBT) (“Weikang” or the “Company”), a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People’s Republic of China, today announced that the Company is launching a new project to research and develop [...]

→ Read the full story | No discussion yet

Weikang Bio-Technology Financial Results

Posted in Corporate Finance News on 08. Jun, 2010

Weikang Bio-Technology Group Co., Inc. (OTC Bulletin Board: WKBT) (“Weikang” or the “Company”), a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription pharmaceuticals and other health and nutritional products in the People’s Republic of China, today announced its financial results for the first quarter of fiscal year 2010 ended on March [...]

→ Read the full story | No discussion yet